630 related articles for article (PubMed ID: 9264077)
1. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
[TBL] [Abstract][Full Text] [Related]
2. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
[TBL] [Abstract][Full Text] [Related]
3. Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat.
Ushijima I; Mizuki Y; Ukita T; Kaneyuki H; Inano S; Yamada M
Pharmacol Biochem Behav; 1992 Nov; 43(3):673-6. PubMed ID: 1360158
[TBL] [Abstract][Full Text] [Related]
4. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
Verma A; Kulkarni SK
Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic methamphetamine on SCH23390- or haloperidol-induced catalepsy, and effects of coadministration of SCH23390 or haloperidol in mice.
Mizuki Y; Ushijima I; Yamada M
Pharmacol Biochem Behav; 1996 Feb; 53(2):437-40. PubMed ID: 8808155
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
[TBL] [Abstract][Full Text] [Related]
8. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.
Ushijima I; Mizuki Y; Yamada M
Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811
[TBL] [Abstract][Full Text] [Related]
9. Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
Glenthøj B
Psychopharmacology (Berl); 1993; 113(2):157-66. PubMed ID: 7855176
[TBL] [Abstract][Full Text] [Related]
10. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
[TBL] [Abstract][Full Text] [Related]
11. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
Zhou LW; Zhang SP; Connell TA; Weiss B
J Pharmacol Exp Ther; 1993 Feb; 264(2):824-30. PubMed ID: 8094754
[TBL] [Abstract][Full Text] [Related]
12. D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
Marin C; Parashos SA; Kapitzoglou-Logothetis V; Peppe A; Chase TN
Pharmacol Biochem Behav; 1993 May; 45(1):195-200. PubMed ID: 8516358
[TBL] [Abstract][Full Text] [Related]
13. Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics.
Undie AS; Friedman E
Psychopharmacology (Berl); 1988; 96(3):311-6. PubMed ID: 2906152
[TBL] [Abstract][Full Text] [Related]
14. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
Braun AR; Laruelle M; Mouradian MM
J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
[TBL] [Abstract][Full Text] [Related]
15. Effects of pertussis toxin on behavioral responses during different withdrawal periods from chronic cocaine treatment.
Ushijima I; Mizuki Y; Kobayashi T; Aoki T; Suetsugi M; Usami K; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1369-77. PubMed ID: 11125860
[TBL] [Abstract][Full Text] [Related]
16. NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.
Moore NA; Blackman A; Awere S; Leander JD
Eur J Pharmacol; 1993 Jun; 237(1):1-7. PubMed ID: 8359205
[TBL] [Abstract][Full Text] [Related]
17. [On filo- and ontogenetic development of dopaminergic regylation of wakefulness-sleep cycle in vertabrates].
Oganesian GA; Aristakesian EA; Romanova IV; Vataev SI; Kuzik VV
Ross Fiziol Zh Im I M Sechenova; 2012 Oct; 98(10):1213-27. PubMed ID: 23401916
[TBL] [Abstract][Full Text] [Related]
18. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
Ushijima I; Noda Y; Mizuki Y; Yamada M
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system.
Zarrindast MR; Sroushi A; Bananej M; Vousooghi N; Hamidkhaniha S
Eur J Pharmacol; 2011 Dec; 672(1-3):106-12. PubMed ID: 21968140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
